Developmentally regulated responsiveness to transforming growth factor-β is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells

Important functional differences exist between primitive CD34⁺+CD38^- hematopoietic progenitor cells derived from human fetal liver (FL) and adult bone marrow (ABM). FL progenitors are known to have higher proliferative capacities and lower cytokine requirements than their ABM counterparts. In this study, we isolated FL and ABM CD34⁺+CD38^- cells and used a two-stage culture system to investigate the effects of transforming growth factor-β (TGF-β) and blocking anti-TGF-β antibodies (anti-TGF-β) on these cells. First, we demonstrate that FL progenitors are significantly less sensitive to the inhibitory effects of TGF-β than ABM cells. Second, whereas ABM cells are significantly stimulated by anti-TGF-β, only very limited effects are seen on FL cells. Third, we show that the effect of anti-TGF-β is mainly situated at the level of the initial cell cycles of very primitive progenitor cells with a high proliferation potential. Fourth, we demonstrate that blocking the effects of endogenous TGF-β reduces the growth factor requirements of ABM cells in order to proliferate and differentiate. Based on these data, we hypothesize that at least part of the functional differences that exist between adult and fetal stem cells can be accounted for by a developmental different responsiveness to TGF-β.